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Abstract
Pulmonary epithelial cell responses can enhance type 2 immunity and contribute to control
of nematode infections. An important epithelial product is the collectin Surfactant Protein D
(SP-D). We found that SP-D concentrations increased in the lung following Nippostrongylus
brasiliensis infection; this increase was dependent on key components of the type 2 immune
response. We carried out loss and gain of function studies of SP-D to establish if SP-D
was required for optimal immunity to the parasite. N. brasiliensis infection of SP-D-/- mice
resulted in profound impairment of host innate immunity and ability to resolve infection.
Raising pulmonary SP-D levels prior to infection enhanced parasite expulsion and type 2
immune responses, including increased numbers of IL-13 producing type 2 innate lymphoid
cells (ILC2), elevated expression of markers of alternative activation by alveolar macro-
phages (alvM) and increased production of the type 2 cytokines IL-4 and IL-13. Adoptive
transfer of alvM from SP-D-treated parasite infected mice into naïve recipients enhanced
immunity to N. brasiliensis. Protection was associated with selective binding by the SP-D
carbohydrate recognition domain (CRD) to L4 parasites to enhance their killing by alvM.
These findings are the first demonstration that the collectin SP-D is an essential component
of host innate immunity to helminths.
Author Summary
Infections by parasitic worms are very common, and controlling them is a major medical
and veterinary challenge. Very few drugs exist to treat them, and the parasites can develop
resistance to these. In order to find new ways to control worm infections, understanding
how our immune system responds to them is essential. Many important parasitic worm
infections move through the host lung. In this study we show that a major secreted protein
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in the lung, Surfactant Protein D (SP-D), is essential for immunity to a parasitic worm
infection. We found that this protein binds to worm larvae in the lung to help the immune
system kill them. Infecting mice that do not express SP-D with worms demonstrates SP-D
is important in this immune response. These mice are unable to launch an effective anti-
worm immune response and have many more worms in their intestine compared to mice
that do express SP-D. We also show that if we increase SP-D levels in the lung the mouse
has better immunity to worms. Together this shows for the first time that SP-D is very
important for immunity to worm infections.
Introduction
Surfactant Protein (SP)-D is a constitutively expressed C-type lectin, which has a well recog-
nized role in innate pulmonary immunity against viruses, bacteria and fungi, as well as in
maintaining pulmonary homeostasis [1]. Direct SP-D interactions with immune (such as alve-
olar macrophages [2]) and non-immune cells [3] can protect against immune pathologies such
as chronic obstructive pulmonary disorder (COPD): SP-D-deficient (SP-D-/-) mice develop
spontaneous chronic lung inflammation and emphysema [4], which can be prevented by
recombinant SP-D replacement [5]. SP-D binding of pathogens and allergens is also important
for preventing or reducing the onset of pathology following infections such as respiratory syn-
cytial virus (RSV) and influenza, and also protects against airway inflammation [6, 7].
SP-D is primarily secreted by alveolar epithelial type II (ATII) cells [1]; ATII cells also
secrete type 2 associated alarmins such as IL-33, which are important for immunity to hel-
minth infections [8]. SP-D also both controls and is controlled by type 2 immune responses;
the canonical type 2 cytokines IL-4 and IL-13 enhance pulmonary SP-D concentrations, yet in
the absence of SP-D CD4+ TH2 cytokine levels are raised [9]. SP-D therefore is likely to play
an important role in limiting overzealous type 2 responses and immune-associated pathology
in the lung. Control of TH2 associated immune pathologies can also be achieved by induction
of regulatory innate immune cell phenotypes, such as alternatively activated macrophages
(AAM) [10]. SP-D can also interact directly with myeloid cells to enhance antigen or pathogen
clearance by macrophages, and also to regulate potentially damaging macrophage-driven
inflammatory responses [5, 11].
Helminth infections are likely to have contributed to the evolution of both type 2/TH2
immunity and associated mechanisms that regulate the strength of this response [12, 13]. Host
protective immunity against helminths is typically TH2-dependent and is initiated by parasite
interaction with epithelial cells, including ATII cells [8]. Regulation of the magnitude of this
TH2-mediated immune response by, for example, regulatory T cells is important for prevent-
ing immunopathology [14, 15]. How innate host factors, such as C-type lectins, are induced by
helminth infection to control infection or regulate host immunity is not well understood. Some
C-type lectins have been associated with helminth infection and host immunity to them. For
example, Dectin-2 contributes to S.mansoni driven inflammasome activation [16]. Only one
previous report has identified any interaction between SP-D and helminths; specifically that
SP-D binds to fucose residues on the tegument of Schistosoma mansoni [17] however, this
study did not address if this interaction contributed to host immunity.
In the study presented here we demonstrate that infection with the experimental model
nematode Nippostrongylus brasiliensis induced a striking type 2-dependent increase in the lev-
els of host SP-D. This induction of SP-D was associated with an increase in type-2 anti-parasite
immune responses. Moreover, we found that immunity to infection required direct interaction
SP-D and Immunity to Helminths
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of SP-D with both the fourth stage (L4) larvae and host alveolar macrophages, driving the latter
to an enhanced AAM phenotype. SP-D therefore represents a previously un-described but piv-
otal mechanistic contributor to host immunity to helminth infection.
Results
Increased SP-D levels following N. brasiliensis infection are dependent
on IL-4/IL-13 cytokine levels and IL-4Rα expression
Type 2 cytokine-associated increases in SP-D levels have previously been shown in bronchoal-
veolar lavage (BAL) and serum of mice following challenge with a range of antigens and patho-
gens [1], but not helminths. Since the lung is an important site for immunity to N. brasiliensis
infection [18, 19], we examined if host immunity to N. brasiliensis infection increased pulmo-
nary and systemic levels of SP-D. Analysis of BAL (Fig 1A) and serum (S1A Fig) of N. brasi-
liensis-infected mice showed a temporal relationship between SP-D levels and progression and
resolution of N. brasiliensis infection. The highest levels of SP-D were found at the peak of
infection; namely day 7 post primary infection in both BAL and serum, highlighting an associa-
tion with host protective immunity to N. brasiliensis. SP-D production has been shown to be
dependent on IL-4, IL-13 and STAT6 [9]. Immunity to N. brasiliensis results in enhanced host
secretion of IL-4 and IL-13, with IL-13 being essential for resolution of infection [20]. We
investigated the requirements of IL-4 and IL-13 for SP-D production in response to N. brasi-
liensis infection. WT, IL-4/IL-13-/- mice (Fig 1B) and IL-4Rα-/- mice (Fig 1C) were infected
with N. brasiliensis and, at 5 days post-infection, SP-D levels in BAL fluid and serum (S1B Fig)
were quantified. Significantly higher SP-D levels were found in WTmice when compared to
both IL-4/IL-13-/- and IL-4Rα-/- mice.
SP-D-/- mice demonstrate highly impaired immunity to N. brasiliensis
To test the association between elevated SP-D levels and immunity to N. brasiliensis we
infected wild type C57/BL-6 and SP-D-deficient (SP-D-/-) mice [21] with the parasite and
examined mice at days 9 and 16 post-infection (PI). At day 9 PI SP-D-/- mice had high worm
burdens while wild type mice had resolved the infection, and by day 16 PI SP-D-/- mice had
resolved the infection (Fig 2A). Levels of the cytokine IL-13, essential for resolution of N. brasi-
liensis infection, were significantly reduced at day 9 PI in the intestine, but not the lung, of
SP-D-/- mice when compared to wild type mice (Fig 2B). Equivalent levels of the alarmins IL-
25, IL-33 and TSLP were detected in the lung and intestine of both WT and SP-D-/- mice at
days 9 and 16 PI (Fig 2C).
We also quantified the numbers and proportions of innate lymphoid cells (ILCs) and alveo-
lar macrophages at day 9 post infection to identify if SP-D was required for the development of
these cells, which are essential for optimal resolution of N. brasiliensis infection. Numbers and
proportions of ILCs, which are required for resolution of N. brasiliensis infection [22], were sig-
nificantly reduced at day 9 PI (Fig 2D). Proportions and numbers of alveolar macrophages
(AlvM) was significantly increased in SP-D-/- mice when compared to wild type mice (Fig 2E).
However, expression of a hallmark of alternative activation, resistin-like molecule (RELM)
alpha/FIZZ1 (RELM-α), within AlvM was significantly decreased in SP-D-/- mice compared to
wild-type by day 9 post-infection (Fig 2E). Additionally, analysis of total RELM-α protein lev-
els in the lung revealed a significant reduction of RELM-α levels in SP-D-/- mice when com-
pared to WT, although total levels of YM1 were equivalent in both groups (Fig 2F and S2 Fig).
To establish if expression of SP-D in the lung alone was sufficient to confer protection we
infected mice capable of doxycycline-inducible expression of SP-D only in the lung (CCSP-
SP-D and Immunity to Helminths
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rtTA, (tetO)7-rSP-D,SP-D
−/−). Significantly reduced N. brasiliensis numbers in the intestine in
doxycycline treated mice (SP-Don) when compared to untreated mice (SP-Doff) demonstrated
that SP-D expression in the lung is a major component of host immunity against N. brasiliensis
(S2 Fig). However, numbers of worms in SP-Don mice were significantly higher than in WT
mice indicating possible SP-D mediated inputs to immunity at other sites.
Fig 1. Elevation of SP-D in BAL fluid followingN. brasiliensis infection is dependent on IL-4/IL-13 and
IL-4Rα. SP-D levels were measured by ELISA in BAL fluid at various time points post N. brasiliensis infection
(a). SP-D levels in IL-4/IL-13-/- (b) and IL-4Rα-/- mice (c) were measured in BAL fluid at day 5 PI and
compared to wild type controls. Data are representative of 3 individual experiments. N = 5 mice per group.
*P<0.05, **P<0.01.
doi:10.1371/journal.ppat.1005461.g001
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SP-D preferentially binds to lung stage L4 N. brasiliensis to enhance
host immunity to the parasite
SP-D control of infection is associated with its ability to opsonize and enhance immune recog-
nition of pathogens. We assessed the ability of a recombinant homotrimeric fragment of
human SP-D (rfhSP-D) to directly bind to N. brasiliensis by immunofluorescence using third
stage larvae (L3), fourth stage larvae (L4), and adult worms. rfhSP-D binding to the surface of
parasites was only seen for L4 (Fig 3A and S3 Fig). Moulting of N. brasiliensis L3 to L4 takes
place in the lungs of the host. This would suggest that elevated pulmonary SP-D levels seen in
the lung (Fig 1) could induce protective immunity by coating L4 parasites and enhanced
Fig 2. Immunity to N. brasiliensis is impaired in SP-D-/- mice. N. brasiliensis infected wild type and SP-D-/- mice were killed at days 9 and 16 PI. Intestinal
worm burdens were quantified (a). Levels of lung and intestinal tissue IL-13 (b), IL-33, TSLP and IL-25 (c)were established by ELISA at days 9 and 16 PI.
FACS analysis established proportions and total numbers of ILC (d). Numbers and proportions of alveolar macrophage and mean fluorescence intensity
(MFI) of RELM-α detection within this population (e).Relative concentration of RELM-α in the lungs of day 9PI WT and SP-D-/- mice was detected by
Western Blot and quantified by densitometry (f). Data are representative of 2–3 individual experiments with N = 4–6 mice per group. *P<0.05, **P<0.01.
doi:10.1371/journal.ppat.1005461.g002
SP-D and Immunity to Helminths
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immune recognition of these parasites both in the lung and intestine. We tested this by infect-
ing mice intranasally with rfhSP-D-coated L4, prior coating with rfhSP-D did not result in
reduced parasite viability (S3 Fig). Intranasal infection of mice with rfhSP-D-coated L4
resulted in reduced worm burdens when compared to mice that received L4 alone (Fig 3B).
Examination of host alarmin responses revealed no effect on IL-33 or IL-25, but a significant
reduction in TSLP (Fig 3C). Recipients of rfhSP-D-coated L4 had increased numbers of ILC2
while AlvM populations showed a heightened expression of the markers of alternative activa-
tion RELM-α chitinase-3-like protein Chil3 (Ym1) (Fig 3D).
Intra-nasal administration of rfhSP-D enhances protective immunity to N.
brasiliensis
Having established in a loss-of-function system that SP-D is required for immunity to N. brasi-
liensis and that rfhSP-D binding of L4 parasites could enhance host immunity to the infection
we next tested if heightened levels of pulmonary SP-D prior to N. brasiliensis infection con-
ferred enhanced immunity against the parasite. Naïve mice treated with rfhSP-D for 4 days did
not display detectable levels of IL-13 or IL4 in the lung. Numbers and proportions of ILC2s
were also equivalent (S4 Fig). At day 5 post-infection, intra-nasal administration of rfhSP-D
prior to N. brasiliensis infection (Fig 4A) significantly reduced intestinal burdens of adult N.
Fig 3. Selective SP-D binding to L4Nippostrongylus brasiliensis enhances host protective immunity. Confocal microscopic images of L3, L4 and
Adult stage of N. brasiliensis incubated with 20 μg/ml of rfhSP-D, biotin-conjugated anti-rfhSP-D, followed by streptavidin-cy3 (a). 250 L4 stage larvae, coated
or uncoated with rfhSP-D were intra-nasally administered into naïve mice. Intestinal worm burden (b), detection by ELISA of IL-33, TSLP and IL-25 in the lung
(c), percentage of lung ILC2 and mean fluorescence intensity (MFI) of markers of alternative macrophage activation were quantified at day 5 PI. (d). Data are
representative of 4 individual experiments. N = 5–8 mice per group. *P<0.05, **P<0.01.
doi:10.1371/journal.ppat.1005461.g003
SP-D and Immunity to Helminths
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brasiliensis in rfhSP-D-treated mice compared to bovine serum albumin (BSA)-treated con-
trols (Fig 4B). Protection was associated with increased pulmonary type 2 cytokines IL-4 and
IL-13 but not IL-33 at day 5 post infection (Fig 4C). Additionally, type 2 innate lymphoid cells
(ILC2) required to control N. brasiliesis infection were increased in numbers and proportions
in the lung of rfhSP-D treated mice. Moreover, a higher percentage of ILC2s produced IL-13 in
rfhSP-D treated mice when compared to untreated mice (Fig 4D).
SP-D-treated AlvMs show increased alternative activation and enhance
host immunity to N. brasiliensis
SP-D is known to regulate alveolar macrophage function [23, 24]. SP-D-/- mice have a loss of
homeostatic regulation of macrophage function [25, 26] which can be rescued by treatment
Fig 4. Intra-nasal administration of SP-D enhances protective immunity toN. brasiliensis. rfhSP-D treated or untreated mice infected withN.
brasiliensiswere killed at day 5 PI. (a). Intestinal worm burdens were quantified at day 5 PI. (b). IL-4, IL-13 and IL-33 cytokine levels in lung homogenates
were detected by ELISA at day 5 PI. (c). Total numbers, total percentage and percentage of IL-13 positive lung ILC2s (d) were quantified by FACS analysis at
D5 PI Black bars: control mice. White bars: SP-D treated mice. Data are representative of 2–3 experiments. N = 5–6 mice per group. *P<0.05, **P<0.01.
doi:10.1371/journal.ppat.1005461.g004
SP-D and Immunity to Helminths
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with recombinant rat SP-D [11]. Host control of N. brasiliensis recall infection is dependent on
IL-4Rα-dependent macrophage polarization to the alternatively activated phenotype in the
lung [27]. AAMs are also key effector cells for controlling other helminth infections including
Heligmosomoides polygyrus [28] and Schistosoma mansoni [29]. As SP-D enhanced immunity
to N. brasiliensis in the lung, we hypothesized that this may be due, at least in part, to an effect
on polarisation of AlvM to AAM.
Intranasal administration of rfhSP-D resulted in an increased expression of the AAMmark-
ers YM1 and Relm-α in AlvMs when compared to BSA-treated controls at day 5 post-infection
(Fig 5A). To test if these SP-D-dependent enhanced AAM response contributed to increased
protection against N. brasiliensis, we isolated AlvMs from mice which had been infected with
N. brasiliensis and treated with rfhSP-D or not, and transferred these cells intra-nasally into
naïve mice. Recipients of rfhSP-D-treated macrophages had reduced intestinal worm burdens
at day 5PI when compared to recipients of untreated macrophages (Fig 5B and S5 Fig).
It is typically considered that polarization to alternative activation by macrophages follow-
ing an N. brasiliensis infection is a result of them responding to elevated levels of the cytokines
IL-4 and IL-13 [30]. We directly tested in vitro whether rfhSP-D enhanced alternative activa-
tion of AlvMs isolated from naïve mice. Naïve AlvMs were polarized to AAM by ex vivo culture
Fig 5. SP-D-induced protection is mediated by enhanced alternative activation of alveolar macrophages.Mean fluorescence intensity (MFI) of Ym1
and RELM-α expression on alveolar macrophages at day 5 PI rfhSP-D treated or untreated mice (a). Macrophages isolated from lungs of infected rfhSP-D
treated or untreated mice were intra-nasally transferred into naïve BALB/c mice. Mice were then infected with N. brasiliensis and worm burdens were
quantified at day 5 PI (b). 4 x 105 macrophages sorted from naïve lungs were cultured with either IL-4/IL-13 (black), rfhSP-D and IL-4/IL-13 (grey) or
untreated (white) and RELM-α and Ym1 expression was quantified by FACS (c). Data are representative of 2–3 experiments. N = 5–8 mice per group.
*P<0.05, **P<0.01, ***P<0.001.
doi:10.1371/journal.ppat.1005461.g005
SP-D and Immunity to Helminths
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with recombinant IL-4/IL-13 in the presence or absence of rfhSP-D. Co-culture with rfhSP-D
increased Ym1 and RELM-α expression when compared to macrophages treated with IL-4/IL-
13 alone (Fig 5C). Collectively, these data show that SP-D can enhance AAM-dependent
immunity to N. brasiliensis.
SP-D enhances macrophage killing of N. brasiliensis by CRDmediated
binding of L4 parasites
SP-D typically confers protection against infection by binding of the carbohydrate recognition
domain (CRD) to the pathogen and, improving opsonisation and neutralization [31]. We
tested if such an interaction contributed to SP-D-induced protection against N. brasiliensis.
The ability of the rfhSP-D CRD domain to bind antigen can be blocked with maltose. We used
this approach to block the ability of rfhSP-D to bind via the CRD to N. brasilieinsis. Mice
treated with maltose-blocked rfhSP-D had higher worm burdens than mice treated with
rfhSP-D alone; moreover, mice treated with rfhSP-D blocked with maltose did not demonstrate
enhanced ILC2 and AAM responses seen in mice treated with rfhSP-D alone (Fig 6A).
We next tested if rfhSP-D opsonisation of L4 N. brasiliensis could enhance killing by alveo-
lar macrophages. Macrophages isolated into serum-free medium from the lungs of N.
Fig 6. SP-D-mediated protection againstN. brasiliensis infection requires carbohydrate recognition domain binding to opsonise L4 for enhanced
macrophage killing.Mice were treated with BSA, rfhSP-D or maltose bound rfhSP-D. Intestinal worm burdens were quantified at day 5 PI, and alveolar cell
populations were determined at day 5 PI (a). UntreatedN. brasiliensis L4 or N. brasiliensis L4 pre-incubated with 20 μg/ml SP-D were cultured without or with
alveolar macrophages (isolated from day 7 N. brasiliensis infected mice) for 48 hrs in serum free media and analysed by microscopy for viability (b). Top row
shows bright field, bottom row shows standard deviation of overlay of 20 sequence pictures; white indicates movement. Data are representative of two
individual experiments. N = 5 mice per group. *P<0.05, **P<0.01.
doi:10.1371/journal.ppat.1005461.g006
SP-D and Immunity to Helminths
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brasiliensis infected mice were added to L4 N. brasiliensis in the presence or absence of
rfhSP-D. In the presence of rfhSP-D and alveolar macrophages the ratio of live to dead para-
sites decreased when compared to parasites cultured with macrophages only (Fig 6B).
Discussion
To date it has never been demonstrated if SP-D or any other member of the collectin sub-fam-
ily of C-type lectins can directly mediate innate protection against a parasitic helminth. In this
study we show for the first time that SP-D is an important component of innate immunity to
helminth infection.
We find that levels of SP-D in the lung and serum increase significantly and rapidly, in a
manner analogous to an alarmin response, following infection with N. brasiliensis. This is in
agreement with other reports where SP-D levels increase in response to acute lung stress fol-
lowing pulmonary challenges with, for example, lipopolysaccharide [32], bleomycin [33] and
ovalbumin [34] Similarly, SP-D levels increase in the BAL following infections by Aspergillus
fumigatus [35], Actinobacillus pleurpneumoniae or Staphylococcus aureus [36]. Our data repre-
sents the first known report of increased SP-D levels in response to a helminth infection.
Elevated SP-D production can also be driven by the type 2/TH2 cytokines IL-4 and IL-13,
and in turn SP-D can impart negative feedback control of type 2/TH2 responses; indeed in the
absence of SP-D TH-2 cytokine levels are raised [9]. Our findings expand on this understand-
ing by demonstrating that production of SP-D following helminth infection is significantly
dependent on key protective immune responses against N. brasiliensis; namely IL-4/IL-13 sig-
naling via IL-4Rα. Previous demonstrations of increased type 2 immunity in SP-D-/- mice [9]
may have suggested that immunity to N. brasiliensis infection [37] would have been enhanced
in SP-D-/- mice. This was not the case and we account for this by exploring other roles for
SP-D in controlling N. brasiliensis infections. Our results demonstrated that SP-D deficiency
impaired innate type-2 responses associated with immunity to N. brasiliensis infection [14];
moreover, we also found that elevated SP-D enhances these responses. This suggests that SP-D
is an important modulator of protective ILC2 and alveolar macrophage responses against N.
brasiliensis.
Opsonisation of pathogens and allergens by SP-D enhances host neutralization of them in
the lung, primarily by improved recognition by host cells, such as alveolar macrophages [38]. It
is well established that SP-D opsonization enhances innate immunity against a range of patho-
gens, such as bacteria, fungi and viruses [39]. We demonstrate that SP-D can also act as an
interface between the L4 parasite and alveolar macrophages (which are key effector cells for
controlling the parasite in the lung [27]). Moreover, direct interaction of SP-D with alveolar
macrophages enhanced their polarization to an alternative phenotype. These findings demon-
strate a pivotal role for alveolar macrophages in mediating the effects of SP-D via macrophage
alternative activation dependent parasite immunity.
In accordance with studies demonstrating the requirement of the carbohydrate recognition
domain (CRD) in mediating pathogen binding and enhanced phagocytosis and clearance by
neutrophils and macrophages [31], our studies also demonstrate that SP-D-dependent clear-
ance of N. brasiliensis is dependent on the CRD. Furthermore, SP-D binding through the CRD
promotes innate type 2 responses including ILC2 induction and alternative activation of alveo-
lar macrophages. We also show that SP-D can directly enhance L4 killing by alveolar macro-
phages following exposure to N. brasiliensis infection. These data clearly show that SP-D can
act as an opsonin of L4 N. brasiliensis to enhance parasite killing by alveolar macrophages.
Our results therefore clearly demonstrate that binding of SP-D to the L4 lung stage of N.
brasiliensis promotes parasite clearance via induction of innate type 2 responses including
SP-D and Immunity to Helminths
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alternative activation of macrophages but also enhanced ILC2 expansion. To the best of our
knowledge this is the first description of SP-D influencing ILC2 biology and we suggest that
the decreased type 2 cytokine levels in the lungs may be a function of a loss of an interaction
between ILC2 and SP-D in SP-D-/- mice.
Additionally, our in vivo studies show that SP-D deficiency increased the proportions of
alveolar macrophages in the lung, key cells that maintain lung homeostasis and promote para-
site clearance [10, 27]. Our observation of increased alveolar macrophage numbers is in agree-
ment with other studies showing increased numbers of alveolar macrophage numbers in
SP-D-/- mice [40]. However, reduced expression of the markers of alternative macrophage
activation such as RELM-α within alveolar macrophages suggests that SP-D-deficiency does
not favour induction of resolving macrophage populations in response to N. brasiliensis infec-
tion. Moreover, we show that in the absence of SP-D total levels of RELM-α in the lung were
significantly reduced. Like SP-D, RELM-α regulates type 2 immunity; RELM-α-/- mice develop
heightened pathology following experimental S.mansoni infection [41]. Therefore, in addition
to having impaired induction of AAM to act directly on the parasite SP-D-/- mice lack appro-
priate induction of other mediators of immune regulation which may have a wider impact on
host control of infection induced pathology [15].
Induction of type 2 immunity to helminths is significantly dependent on epithelial cells
(including ATII cells, the main cellular source of SP-D) secreting cytokines such as IL-33 [8]
along with other immune modulators such as RELM-ß [42], trefoil factor 2 (TFF2) [43] and
TSLP [44]. Our findings show that helminth induced SP-D is an additional major player in the
host epithelial response to helminths. Balanced type 2 immunity is characteristic of effective
host control of parasitic helminth infections and also reduced susceptibility to allergic disease
[14]. Our findings therefore may have broader relevance to understanding innate immune con-
trol of diseases associated with poor control of type 2/Th2 immunity. Moreover, as helminth-
induced SP-D is able to modify innate cell function and directly control lung inflammation,
our studies set a precedent for placing SP-D in a central role of mediating parasite-associated
protection from, for example, allergy and pulmonary viral infection
In conclusion, we show for the first time in both gain of function and loss function
approaches that SP-D is required for immunity against N. brasiliensis. This enhanced immu-
nity is coincident with an increased induction of cells associated with the resolution of infec-
tion; namely ILC2 and alternatively activated macrophages. Thus, helminth induction of SP-D
is essential for host resolution of helminth infection.
Materials and Methods
Ethics statement
6-10-week-old BALB/c, C57/BL6, IL-4/13-/-[45], IL-4Rα-/-[46], SP-D-/- and CCSP-rtTA,
(tetO)7-rSP-D,SP-D
−/− [21, 47] mice were obtained from colonies maintained by the Univer-
sity of Cape Town specific-pathogen-free animal facility. The authors are grateful to the labora-
tories of J Whitsett and S Hawgood for use of SP-D transgenic mice originally generated in
their laboratories. Section 20 dispensation to carry out animal work at UCT was granted
nationally by the South African Government Department of Agriculture Fisheries and Food
and institutionally by the UCT Health Sciences Animal Ethics Committee (Project licence 012/
054) to be in accordance with guidelines laid down by the South African Bureau of Standards.
All researchers were accredited by the South African Veterinary Council. Dispensation to carry
out animal research at Imperial College was approved by the Imperial College Animal Welfare
and Ethical Review Body and granted by the UK government Home Office; as such all research
here was carried under a specific project licence (PPL70/6957).
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N. brasiliensis infection
Mice were infected subcutaneously with 500 N. brasiliensis L3 larvae and killed at various times
post infection as previously described [48]. Intra-nasal infection with rfhSP-D coated L4 N.
brasiliensis was carried out using techniques adapted from Harvie et al [19]. Briefly, L4 N. bra-
siliensis were isolated 2 days post- N. brasiliensis infection from lung tissues. L4 N. brasiliensis
were then incubated with rfhSP-D or bovine serum albumin (BSA) control for 1 hour at 37°C.
L4 N. brasiliensis infection of mice was carried out by intranasal administration of 250 viable
L4 worms in 50 μl to lightly anaesthetized mice. Adult worm burdens were determined by
removing the small intestine and exposing the lumen by dissection. The intestines were incu-
bated at 37°C for 4 hrs in 0.65% sodium chloride (NaCl) to allow the worms to migrate out,
after which the numbers of worms were counted under a dissecting microscope.
Intra-nasal administration of rfhSP-D
Mice were lightly anaesthetized and treated with 20 μg of rfhSP-D or BSA control (diluted in
PBS) intra-nasally in a volume of 50 μl on day 0, 1, 2 and 3. For blocking of rfhSP-D CRD head
region, 20 mMMaltose was incubated with rfhSP-D in the presence of 1 mM calcium chloride
(CaCl2) for 1 hr at 37°C. Mice were killed on days indicated in results.
BAL fluid, lung homogenates and serum
Mice underwent bronchoalveolar lavage (BAL) by administration of 1 ml sterile PBS contain-
ing 0.25 mM Ethylenediaminetetraacetic acid (EDTA) intra-tracheally. Lungs were lavaged
three times. BAL fluid was centrifuged at 1200 rpm for 5 mins and the supernatant was frozen
at -80°C.
The left lobe of the lung was snap frozen in liquid nitrogen and subsequently stored at
-80°C until analysis. To prepare lung homogenates, 400 μl of lysis buffer [49] was added to
lung tissue prior to mechanical homogenization. Homogenates were centrifuged at 14000 rpm
for 20 mins and the protein concentrations of the supernatants determined using bicinchoninic
acid (BCA) assay (Pierce, Rockford, IL).
Approximately 500 μl of blood was collected by cardiac puncture and the serum isolated by
centrifugation (4000 rpm for 20 mins).
Preparation of single cell-suspension of lung tissue
Whole lungs were removed from individual mice, finely cut and digested in Iscove’s modified
Eagle medium (IMDM) (Invitrogen) containing 50 U/ml collagenase type I (Invitrogen) and
13 μg/ml DNase (Roche) at 37°C for 90 mins. Digested lung tissue were pushed through 70 or
100 μm nylon cell strainer (Becton Dickson, New Jersey) and subjected to red cell lysis.
Flow cytometry
1 x 106 single cell suspensions from individual lungs were stained in MACS buffer with anti-
Siglec-F PE (E50/2440) and anti-CD11c APC (HL3) antibodies to stain for AlvMs and eosino-
phils. To stain for ILC2, the antibodies anti-Lineage PE (CD3, CD19, CD11b, FceR1, Ter119,
CD4, CD8, B220, Ly6G/6C), anti-CD45 AF700, anti-CD90 PacBlu, anti-CD127 PE-Cy7 or
APC (SB/199), anti-ICOS Biotin or FITC (7E.17G9) anti- Sca-1 V450 (D7) and anti-T1/ST2
FITC PerCP-Cy5.5 (DJ8) were used. Anti-FcR (2.4G2) was used to block non-specific binding
of immunoglobulins to the FCγII/III receptors.
For intracellular staining, cells were stained with surface markers, fixed in 2% paraformalde-
hyde before being permeabilized with buffer containing saponin. Cells were subsequently
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stained with anti-Ym1 biotin (ECF-L) and anti-RELM-α (E19). For intracellular staining of
ILC2 cells were fixed and permeabilized with Fix/perm (eBioscience) and stained with IL-13
PE-Cy7. Cells were acquired using a FORTESSA Flow cytometer (BD Biosciences) and data
analyzed using FlowJo software (Tree star, inc., Ashland, Oregon, USA). Antibodies were pur-
chased from BD Pharmingen, eBioscience and Biolegend.
Enzyme-linked immunosorbent assay (ELISA) analysis
Whole lung and intestine homogenates were used to quantify cytokines, and BAL fluid or
serum from N. brasiliensis infected mice were analyzed for SP-D content by ELISA. 96-well
flat-bottom plates (Nunc Maxisorp; Thermo Fisher Scientifica, Roskilde, Denmark) were
coated overnight at 4°C with 50 μl of appropriate coating antibody diluted in 1X PBS. Plates
were washed four times in Tris-Buffered Saline containing % Tween (TBST), blocked with
200 μl blocking buffer overnight at 4°C. Following this, appropriate dilutions of samples and
standards were prepared, loaded into wells and incubated overnight at 4°C. The plates were
further washed and 50 μl of appropriate biotinylated secondary antibodies were added and
incubated at 37°C for 3 hrs. 50 μl of Streptavidin-coupled horseradish peroxidase (HRP) was
then added after washing and plates were incubated for 1 hr at 37°C. The plates were developed
with 3,3’,5,5’-Tetramethylbenzidine (TMB) microwell peroxidase substrate system, and the
reaction was stopped with 1 M H3PO4. The plates were read at an absorbance of 450 nm using
a VersaMax microplate reader (Molecular Devices Corporation, Sunnyvale, CA, U.S.A). All
antibodies were from BD Pharmingen, San Diego, CA.
Isolation & adoptive transfer experiments
Mice were treated with 20 μg of rfhSP-D or BSA at D0, 1, 2, 3, 6 and 7 post-infection. Single-
cell suspensions of pooled lungs were prepared at day 8 post-infection and AlvMs were stained
with anti-CD11c APC-conjugated and anti-Siglec-F PE conjugated monoclonal antibody
(MAb) (BD Pharmingen) before they were isolated (> 95% purity) as CD11c+Siglec F+Auto-
flourescenthigh using a FACS Aria cell sorter (Becton Dickinson), purity was also confirmed by
microscopic analysis (S5A Fig). 1 x 105 macrophages were then transferred intra-nasally into
naïve BALB/c mice 24 hrs prior to N. brasiliensis infection.
In vitro culture of macrophages with SP-D
Naïve AlvMs (CD11C+Siglec-F+AutoFlourescenthigh) were isolated from single cell suspen-
sions of lung tissue by FACS Aria as described above and plated in duplicates at 4x105 cells per
well. Cells were stimulated with either recombinant mouse IL-4/IL-13, IL-4/IL-13 + 20 μg/ml
of rfhSPD or left untreated. The cultures were incubated for 60 hrs at 37°C. Thereafter, cells
were washed and stained for alternative activation markers, YM1 and Relm- α as described
above, and acquired with LSRFORTESSA (BD Biosciences).
In vitro culture of L4, SP-D and macrophages
Mice were infected with 500 L3 N. brasiliensis and lungs isolated at day 7 post-infection. Single
cell suspensions were stained for Siglec-F and CD11c and live cells isolated into serum free
media using a FACS Aria, as described above. L4 were isolated from lungs as described previ-
ously. Experiments were carried using serum free media. L4 were either left untreated or incu-
bated with 20 μg/ml SP-D for 1 hr before addition to 4x105 macrophages. After 48 hrs larvae
were washed, counted and analysed for movement by bright field microscopy and a sequence
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of 20 images/min were taken. These were then analysed by SD overlay using Fiji software. Live/
dead ratios were calculated using total, moving and dead numbers.
Confocal microscopy
L3, L4 and adult stage larvae of N. brasiliensis were fixed overnight in 2% paraformaldehyde at
4°C. The larvae were extensively washed using 1X PBS containing 0.2% BSA and 1 mM CaCl2.
Non-specific binding was blocked by incubation of the larvae in 0.2% BSA in PBS for 1 hr at
room temperature. Thereafter, the larvae were incubated with 20 μg/ml rfhSP-D in PBS con-
taining 0.2% BSA and 1mM CaCl2 for 1 hr at 32°C. After extensive washing, the larvae were
incubated with biotinylated rabbit anti-rfhSP-D antibody (HYB 246.04, Antibody shop) used
at 1/200 and left overnight at 4°C. To detect the SP-D binding, the organisms were subse-
quently incubated with Streptavidin cy3 (1/500) for 2 hrs at room temperature (RT). All sec-
tions were viewed with Axiovert LSM 510 Meta NLO microscope (Zeiss).
Statistics
Data were expressed as mean ± standard deviation and analyzed using Mann-Whitney non-
parametric T test or ANOVA with a 95% confidence interval. p values are represented as p<
0.05 (), p<0.01 () and p<0.005 ().
Supporting Information
S1 Fig. SP-D is induced in the serum following N. brasiliensis infection and correlates with
the levels in BAL fluid. Kinetics of SP-D levels was measured by ELISA in serum following N.
brasiliensis infection (a). SP-D levels of IL-4/IL-13-/- mice (b) were measured in serum at day 5
PI and compared to wild type controls. Data are representative of one individual experiment.
N = 5 mice per group. P<0.01.
(TIFF)
S2 Fig. Expression of SP-D in the lung contributes significantly to reduced N. brasiliensis
burden in the host. Relative concentration of RELM-α and YM1 in individual lung samples of
day 9 PIWT and SP-D-/- mice as detected byWestern Blot and quantified by densitometry (a).
Data are representative of 2 individual experiments. WT, CCSP-rtTA, (tetO)7-rSP-D,SP-D
−/−
mice–doxycycline (SP-Doff) and CCSP-rtTA, (tetO)7-rSP-D,SP-D
−/−mice + doxycycline
(SP-Don) were infected with 500 x L3N. brasiliensis and intestinal worm burdens established at
day 5 PI (b). Data are representative of 2 individual experiments. N = 4–6 mice per group.
(TIFF)
S3 Fig. Selective SP-D binding to L4 Nippostrongylus brasiliensis enhances host protective
immunity. Labeling of N. brasiliensis parasites with anti-IgG2b isotype control (a). Untreated
N. brasiliensis L4 or N. brasiliensis L4 pre-incubated for 1 hr with either 20 μg/ml BSA or
20 μg/ml SP-D. Worm motility was assessed by time lapse photography (b). Top row shows
bright field, bottom row shows standard deviation of overlay of 20 sequence pictures; white
indicates movement. Data are representative of two individual experiments.
(TIFF)
S4 Fig. Effect of intra-nasal administration of SP-D on naïve lung. BALB/c mice were
treated with 20 μg rfhSP-D for 4 days. IL-4, IL-13 and IL-33 cytokine levels in lung homoge-
nates were detected by ELISA at day 5 PI (a). Total numbers and proportions of lung ILC2s
(b). Data are representative of 2 individual experiments. N = 4 mice per group.
(TIFF)
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S5 Fig. Morphology and immune characterization of adoptively transferred alveolar mac-
rophage populations. Light microscope analysis of macrophage morphology in cells isolated
from N. brasiliensis infected and N.brasiliensis + SP-D treated mice (a). Expression levels of
YM1 and RELM-α on alveolar macrophages isolated from N. brasiliensis infected and N. brasi-
liensis infected + SP-D treated mice (b). Data are representative of 2 individual experiments.
(TIFF)
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